VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $76,236,000 | +39.9% | 3,280,349 | -4.2% | 0.06% | +28.6% |
Q1 2018 | $54,506,000 | -27.3% | 3,423,747 | -5.2% | 0.05% | -24.6% |
Q4 2017 | $75,021,000 | -13.8% | 3,610,256 | -40.6% | 0.06% | -18.8% |
Q3 2017 | $87,080,000 | -20.5% | 6,076,751 | -4.0% | 0.08% | -23.8% |
Q2 2017 | $109,521,000 | +46.5% | 6,330,670 | -6.6% | 0.10% | +47.9% |
Q1 2017 | $74,768,000 | +3.3% | 6,778,655 | +47.9% | 0.07% | -6.6% |
Q4 2016 | $72,386,000 | -15.5% | 4,584,195 | +31.4% | 0.08% | -18.3% |
Q3 2016 | $85,625,000 | +22.8% | 3,487,756 | +0.7% | 0.09% | +17.7% |
Q2 2016 | $69,726,000 | -63.3% | 3,462,030 | -52.1% | 0.08% | -61.1% |
Q1 2016 | $190,030,000 | -51.7% | 7,225,456 | +86.5% | 0.20% | -56.8% |
Q4 2015 | $393,769,000 | -65.7% | 3,873,765 | -39.8% | 0.47% | -70.4% |
Q3 2015 | $1,147,427,000 | -32.5% | 6,432,479 | -15.9% | 1.59% | -20.3% |
Q2 2015 | $1,699,545,000 | +16.8% | 7,650,431 | +4.5% | 1.99% | +18.2% |
Q1 2015 | $1,454,497,000 | +41.6% | 7,323,012 | +2.0% | 1.68% | +44.8% |
Q4 2014 | $1,027,046,000 | +3.8% | 7,176,612 | -4.9% | 1.16% | +3.8% |
Q3 2014 | $989,745,000 | +0.9% | 7,543,784 | -3.0% | 1.12% | +2.3% |
Q2 2014 | $981,189,000 | -7.1% | 7,779,802 | -2.8% | 1.10% | -19.5% |
Q1 2014 | $1,055,626,000 | +81.2% | 8,007,479 | +61.4% | 1.36% | +70.9% |
Q4 2013 | $582,512,000 | +11.7% | 4,961,778 | -0.7% | 0.80% | -1.6% |
Q3 2013 | $521,529,000 | +30.8% | 4,998,844 | +7.9% | 0.81% | +14.6% |
Q2 2013 | $398,759,000 | – | 4,632,430 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |